The Valley Desk

ArticleContemporary clinical trials communicationsPublished

Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvals

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Article
Venue
Contemporary clinical trials communications
Published
Subject terms
Oncology; Combination therapy; Monotherapy; Single-agent Activity; Approval Rate
PubMed ID
41551573
PubMed Central ID
PMC12811421
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal